Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,581 | 711 | 222 | 283 | 569 |
| Receivables | 141 | 187 | 521 | 69 | 104 |
| TOTAL | $11,735 | $938 | $810 | $447 | $796 |
| Non-Current Assets | |||||
| PPE Net | 10 | 9 | 10 | 11 | 10 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $21 | $20 | $21 | $22 | $21 |
| Total Assets | $11,756 | $958 | $831 | $469 | $817 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 436 | N/A | 13 | N/A |
| Accounts payable and accrued liabilities | 162 | 91 | 741 | 153 | 63 |
| Accrued Expenses | 580 | 2,076 | 1,917 | 1,851 | 1,732 |
| TOTAL | $924 | $2,786 | $2,670 | $2,016 | $1,808 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19 | 22 | 25 | 27 | 29 |
| TOTAL | $19 | $22 | $25 | $27 | $29 |
| Total Liabilities | $942 | $2,808 | $2,695 | $2,043 | $1,837 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 254 | 51 | 46 | 46 | 426,306 |
| Common Shares | 4 | 14 | 14 | 0 | 96 |
| Retained earnings | -44,469 | -43,898 | -43,443 | -42,848 | -42,257 |
| TOTAL | $10,814 | $-1,850 | $-1,864 | $-1,575 | $-1,021 |
| Total Liabilities And Equity | $11,756 | $958 | $831 | $469 | $817 |